Literature DB >> 33235374

Sotagliflozin reduces adverse cardiovascular events.

Andrew Robson1.   

Abstract

Year:  2021        PMID: 33235374     DOI: 10.1038/s41569-020-00486-0

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.

Authors:  Deepak L Bhatt; Michael Szarek; P Gabriel Steg; Christopher P Cannon; Lawrence A Leiter; Darren K McGuire; Julia B Lewis; Matthew C Riddle; Adriaan A Voors; Marco Metra; Lars H Lund; Michel Komajda; Jeffrey M Testani; Christopher S Wilcox; Piotr Ponikowski; Renato D Lopes; Subodh Verma; Pablo Lapuerta; Bertram Pitt
Journal:  N Engl J Med       Date:  2020-11-16       Impact factor: 91.245

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.